Cleveland Clinic Children's and UH Rainbow Babies & Children's Hospital rank among top in Ohio, Midwest by U.S. News & World Report
NiveshIQ
NSE: RAINBOW · Healthcare
Rainbow Childrens Medicare Ltd.
₹1,444.90▼ ₹15.20 (-1.04%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on RAINBOW. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Rainbow Childrens Medicare Ltd.
Rainbow Children's Medicare Limited operates a multi-specialty paediatric, obstetrics, and gynaecology hospital chain in India, offering medical and healthcare services to children and women. The company's key revenue drivers include pediatric services under the Rainbow Children's Hospital brand and women care services under the Birthright brand. Recent developments indicate a significant increase in revenue, with consolidated June 2026 net sales rising 33.17% year-over-year to Rs 469.99 crore. This growth is attributed to the company's expanding network of hospitals and increasing demand for its services. Rainbow Children's Medicare Limited has a strong competitive position in the Indian healthcare market, with a reputation for providing high-quality medical care. The company's growth out
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,237 Cr +5.40% | ₹1,455 Cr +17.60% | ₹1,703 Cr +17.10% |
| EBITDA Margin | 33.15% | 32.34% | 34.52% |
| Net Profit | ₹215.00 Cr +1.40% | ₹238.00 Cr +10.70% | ₹283.08 Cr +18.90% |
| EPS | ₹21.17 | ₹23.40 | ₹27.41 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Rainbow Childrens Medicare schedules investor meetings for Sep 18-22
Rainbow Childrens Medicare schedules investor meetings for Sep 18-22
🔒
+ 3 more stories about Rainbow Childrens Medicare Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹470 Cr, PAT ₹63 Cr, EPS ₹5.97, EBITDA margin 31.4%. Growth context: revenue QoQ +2.2%, PAT QoQ -21.6%. Street verdict: beat, revenue surprise +8.0%, PAT surprise +8.8%.
Geographic expansion and international growth are poised to drive the next leg of growth for Rainbow, with management's ...
FY26 (last completed FY): revenue ₹1, 703 Cr, PAT ₹283 Cr, EBITDA margin 34.5%, EPS ₹27.41. Year-on-year: revenue YoY +1...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for RAINBOW
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track RAINBOW alongside your other holdings
Unlock full RAINBOW research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Rainbow Childrens Medicare Ltd.?
NiveshIQ detects active intelligence signals for Rainbow Childrens Medicare Ltd. (RAINBOW) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Rainbow Childrens Medicare Ltd.?
Rainbow Childrens Medicare Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,321,764.4L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.